AVROBIO Granted ILAP Designation from U.K. MHRA for First-in-Class Gene Therapy for Gaucher Disease

ILAP intended to accelerate regulatory review process and facilitate patient access in U.K. for seriously debilitating and life-threatening diseases AVR-RD-02 has previously received Fast Track status from U.S. FDA and orphan drug designation in the U.S. and EU CAMBRIDGE, Mass.–(BUSINESS WIRE)–$AVRO—AVROBIO, Inc. (Nasdaq: AVRO), a leading clinical-stage gene therapy company working to free people from … [Read more…]

BioIntelliSense Acquires AlertWatch® Clinical Intelligence Engine to Expand its Comprehensive Portfolio of Continuous Patient Monitoring Solutions

The FDA-cleared AlertWatch® clinical intelligence and triage system spans healthcare settings and seamlessly integrates with BioIntelliSense’s medical-grade BioButton® wearables for scalable in-hospital patient monitoring and at-home remote care Medtronic Patient Monitoring business to offer AlertWatch solution to U.S. Hospitals DENVER–(BUSINESS WIRE)–BioIntelliSense, Inc., a continuous health monitoring and clinical intelligence company, today announced its acquisition of … [Read more…]

International Nonprofit Longevity Science Foundation Expands to the United States with New CEO

The LSF has expanded its global reach to the U.S. with 501(c)3 status, headquarters in Miami, and the appointment of new CEO and Advisory Board members MIAMI–(BUSINESS WIRE)–#biotech—The Longevity Science Foundation (LSF), a global nonprofit organization providing research funding to establish a longer and healthier human lifespan, has recently expanded by launching operations in the … [Read more…]

Empyrean Neuroscience Launches with $22M Series A and Genetic Engineering Platform to Advance Pipeline of Neuroactive Compounds Targeting CNS Disorders

— Founded on the first and only platform designed to genetically engineer small molecule therapeutics from fungi and plants — — Led by veteran biotech executives Usman Azam, Chief Executive Officer, and Fred Grossman, Chief Medical Officer — NEW YORK & CAMBRIDGE, England–(BUSINESS WIRE)–Empyrean Neuroscience, Inc., a leading genetic engineering company dedicated to developing neuroactive … [Read more…]

Babylon Receives $80 Million in Total Subscriptions for Private Placement Financing

AUSTIN, Texas & LONDON–(BUSINESS WIRE)–Babylon (NYSE: BBLN) (“Babylon” or the “Company”) today announced that it has received its Board of Directors’ authorized maximum of $80 million in total subscriptions (the “Subscriptions”) from institutional and other accredited investors for its previously announced private investment in public equity (the “PIPE”) at a price of $0.42122 per Class … [Read more…]

ADME-Toxicology Testing Global Market Report 2022: Increased Need to Check Late-Stage Drug Failures Drives Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “ADME-Toxicology Testing – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering. Global ADME-Toxicology Testing Market to Reach $12.3 Billion by 2027 In the changed post COVID-19 business landscape, the global market for ADME-Toxicology Testing estimated at US$6 Billion in the year 2020, is projected to reach a revised size … [Read more…]

The Worldwide Antibacterial Coatings Industry is Expected to Reach $1 Billion by 2030 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Antibacterial Coatings Market for Medical Implants By Material, By Type: Global Opportunity Analysis and Industry Forecast, 2020-2030” report has been added to ResearchAndMarkets.com’s offering. The anti-bacterial coatings market for medical implants was valued at $234.42 million in 2020, and is estimated to reach $1,072.27 million by 2030, growing at a CAGR of 16.4% … [Read more…]

Abalos Therapeutics Appoints Thomas Bogenrieder as Chief Medical Officer

DÜSSELDORF, Germany–(BUSINESS WIRE)–Abalos Therapeutics announced today the appointment of Thomas Bogenrieder, MD, PhD, as Chief Medical Officer. Dr. Bogenrieder will contribute more than 17 years of international clinical development experience including successfully guiding cancer immunotherapies through the clinical evaluation process. His expertise in the clinical development of cancer virotherapies will further strengthen the company’s leadership … [Read more…]

Lysando AG and Amicogen Inc. Sign General Development Agreement

TRIESENBERG, Liechtenstein–(BUSINESS WIRE)–#UTI–Lysando AG – market leader in the field of antimicrobial proteins – has signed a general development agreement with Amicogen Inc., a publicly traded biotechnology company and CDMO headquartered in South Korea. In August last year, Lysando and Amicogen entered into a strategic partnership backed up by a mutual participation model. This collaboration … [Read more…]

Vagaro Offering Key Tools to Small Business Owners as U.K. Inflation Remains at Record Highs

LONDON–(BUSINESS WIRE)–As inflation across the U.K. remains at record highs, with reports earlier this year revealing prices rising at the fastest pace in 40 years, Vagaro seeks to lessen the burden of maintaining business operations and financial woes on small business owners during this time. Vagaro, the leading comprehensive business management platform for the beauty, … [Read more…]